FindTrial
Sign In

Use of Platelet indices & neutrophil: lymphocyte ratio for prediction of sickle cell vaso- occlusive crisis

Platelet indices & neutrophil: lymphocyte ratio as a predictive tool in acute sickle cell vaso- occlusive crisis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057843
Enrollment
140
Registered
2023-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D578- Other sickle-cell disorders

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Known cases of sickle cell disease more than 14 years of age Newly detected cases of Sickle cell disease more than 14 years of age

Exclusion criteria

Exclusion criteria: Patients less than 14 years of age Patients with other causes of Thrombocytopenia Patients with Liver or renal disease Patients with malignancy Patients with hereditary disorders of large platelets Patients on Anticoagulants Patients on Antiplatelet agents

Design outcomes

Primary

MeasureTime frame
Platelet indices & neutrophil: lymphocyte ratio will be clinically significant predictors of Acute sickle cell vaso occlusive crisis.Timepoint: Assessment of the patient will be done at the time of admission in the hospital and at the time of discharge—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactDr Satish Mahajan

Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research

mahajandr99@rediffmail.com8329937199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026